9 cancer medicines declared fake and illegal after…
A major health alert has emerged in Karachi after the Sindh Drug Testing Laboratory declared nine medicines used for cancer treatment as substandard, fake, and unregistered. Authorities have started action against the responsible parties following the laboratory findings.
Director Sindh Drug Testing Laboratory Syed Adnan Rizvi said that the investigation was launched after receiving laboratory reports, and relevant institutions have begun taking action based on the results.
According to Rizvi, some of the cancer medicines tested did not contain the required active ingredients needed for treatment, while others did not have a valid registration number from the Drug Regulatory Authority of Pakistan (DRAP).
He warned that the availability of counterfeit and low-quality cancer medicines poses a serious threat to patients because ineffective treatment can allow the disease to progress and reduce the chances of recovery.
The official also raised concerns about prescription practices, stating that some oncologists mention the names of specific pharmacies on prescriptions, which may force patients to purchase medicines only from those outlets. He emphasized the need for transparency and strict monitoring throughout the medicine supply chain.
Cancer medicines are highly sensitive and require accurate composition and quality standards because patients depend on them for life-saving treatment. Experts have repeatedly stressed that fake or substandard drugs can cause severe health consequences, especially for people undergoing critical therapies.
The Sindh Drug Testing Laboratory findings have increased concerns about medicine regulation and quality control in the healthcare sector. Authorities are expected to investigate the source of the suspected medicines, identify those involved in their distribution, and take legal action where necessary.
The incident highlights the importance of purchasing medicines only from authorized pharmacies and ensuring that drugs carry proper registration details and quality certifications. Health officials have urged patients and healthcare providers to remain cautious and report any suspicious medicines to relevant authorities.
Drug safety remains a major challenge in many healthcare systems, and officials say stronger monitoring, improved enforcement, and public awareness are essential to prevent the circulation of counterfeit medicines.
Further details about the investigation and action against those responsible are expected as authorities continue their review of the case.
